Advertisement
Screener

HENRY SCHEIN, INC. (HSIC) Noncontrolling Interest, Change in Redemption Value

2.8 / 5 stars · 68/120 Roast Me

HENRY SCHEIN, INC. Noncontrolling Interest, Change in Redemption Value

HENRY SCHEIN, INC. (HSIC) reported Noncontrolling Interest, Change in Redemption Value of -$16.00 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-04.

Financial Statements › Notes › Noncontrolling Interest

us-gaap:MinorityInterestChangeInRedemptionValue · last filed 2026-08-04

  • HENRY SCHEIN, INC. noncontrolling interest, change in redemption value for the quarter ending 2026-06-27 was -$16.00M.
  • HENRY SCHEIN, INC. noncontrolling interest, change in redemption value for the quarter ending 2026-03-28 was -$18.00M.
  • HENRY SCHEIN, INC. noncontrolling interest, change in redemption value for the quarter ending 2025-12-27 was -$22.00M.
  • HENRY SCHEIN, INC. noncontrolling interest, change in redemption value for the quarter ending 2025-09-27 was -$12.00M.
  • HENRY SCHEIN, INC. noncontrolling interest, change in redemption value for fiscal 2025 was -$72.00M.
  • HENRY SCHEIN, INC. noncontrolling interest, change in redemption value for fiscal 2024 was -$119.00M, a 1181.82% decline from fiscal 2023.
  • HENRY SCHEIN, INC. noncontrolling interest, change in redemption value for fiscal 2023 was $11.00M, a 175.00% increase from fiscal 2022.
  • HENRY SCHEIN, INC. noncontrolling interest, change in redemption value for fiscal 2022 was $4.00M.
Period endNoncontrolling Interest, Change in Redemption Value 3 monthNoncontrolling Interest, Change in Redemption Value 6 monthNoncontrolling Interest, Change in Redemption Value 9 monthNoncontrolling Interest, Change in Redemption Value 12 month
2026-06-27-$16.00M
10-Q · filed 2026-08-04
-$34.00M
10-Q · filed 2026-08-04
-$56.00M
derived: sum of 3 quarters · filed 2026-08-04
-$68.00M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-28-$18.00M
10-Q · filed 2026-05-05
-$40.00M
derived: sum of 2 quarters · filed 2026-05-05
-$52.00M
derived: sum of 3 quarters · filed 2026-05-05
-$62.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-27-$22.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$34.00M
derived: sum of 2 quarters · filed 2026-02-24
-$44.00M
derived: sum of 3 quarters · filed 2026-08-04
-$72.00M
10-K · filed 2026-02-24
2025-09-27-$12.00M
10-Q · filed 2025-11-04
-$22.00M
derived: sum of 2 quarters · filed 2026-08-04
-$50.00M
10-Q · filed 2025-11-04
-$82.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-28-$10.00M
10-Q · filed 2026-08-04
-$38.00M
10-Q · filed 2026-08-04
-$70.00M
derived: sum of 3 quarters · filed 2026-08-04
-$76.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-29-$28.00M
10-Q · filed 2026-05-05
-$60.00M
derived: sum of 2 quarters · filed 2026-05-05
-$66.00M
derived: sum of 3 quarters · filed 2026-05-05
-$105.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-28-$32.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$38.00M
derived: sum of 2 quarters · filed 2026-02-24
-$77.00M
derived: sum of 3 quarters · filed 2026-02-24
-$119.00M
10-K · filed 2026-02-24
2024-09-28-$6.00M
10-Q · filed 2025-11-04
-$45.00M
derived: sum of 2 quarters · filed 2025-11-04
-$87.00M
10-Q · filed 2025-11-04
-$90.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-29-$39.00M
10-Q · filed 2025-08-05
-$81.00M
10-Q · filed 2025-08-05
-$84.00M
derived: sum of 3 quarters · filed 2026-02-24
-$56.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-30-$42.00M
10-Q · filed 2025-05-05
-$45.00M
derived: sum of 2 quarters · filed 2026-02-24
-$17.00M
derived: sum of 3 quarters · filed 2026-02-24
-$34.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-30-$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$25.00M
derived: sum of 2 quarters · filed 2026-02-24
$8.00M
derived: sum of 3 quarters · filed 2026-02-24
$11.00M
10-K · filed 2026-02-24
2023-09-30$28.00M
10-Q · filed 2024-11-05
$11.00M
derived: sum of 2 quarters · filed 2024-11-05
$14.00M
10-Q · filed 2024-11-05
$0.00
derived: sum of 4 quarters · filed 2025-02-25
2023-07-01-$17.00M
10-Q · filed 2024-08-06
-$14.00M
10-Q · filed 2024-08-06
-$28.00M
derived: sum of 3 quarters · filed 2025-02-25
-$17.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-04-01$3.00M
10-Q · filed 2024-05-07
-$11.00M
derived: sum of 2 quarters · filed 2025-02-25
$0.00
derived: sum of 3 quarters · filed 2025-02-25
$10.00M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31-$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$3.00M
derived: sum of 2 quarters · filed 2025-02-25
$7.00M
derived: sum of 3 quarters · filed 2025-02-25
$4.00M
10-K · filed 2025-02-25
2022-09-24$11.00M
10-Q · filed 2023-11-28
$21.00M
derived: sum of 2 quarters · filed 2023-11-28
$18.00M
10-Q · filed 2023-11-28
2022-06-25$10.00M
10-Q · filed 2023-08-07
$7.00M
10-Q · filed 2023-08-07
2022-03-26-$3.00M
10-Q · filed 2023-05-09
2021-12-25-$160.00M
10-K · filed 2024-02-28
2020-12-26-$33.00M
10-K · filed 2023-02-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACCENDRA HEALTH INC/VA/ (ACH)United States$0.057B-0.87